Thrombin time
An article about the thrombin time test in coagulation studies
Thrombin Time[edit | edit source]
The thrombin time (TT) is a blood test that measures the time it takes for a clot to form in the plasma of a blood sample after an excess of thrombin has been added. This test is used to assess the final step of the coagulation process, which is the conversion of fibrinogen to fibrin.
Purpose[edit | edit source]
The thrombin time is primarily used to evaluate the presence of fibrinogen abnormalities, either quantitative or qualitative, and to detect the presence of inhibitors that affect the conversion of fibrinogen to fibrin. It is particularly useful in diagnosing dysfibrinogenemia, hypofibrinogenemia, and the presence of heparin or other direct thrombin inhibitors in the blood.
Procedure[edit | edit source]
In the thrombin time test, a sample of the patient's plasma is mixed with a standardized amount of thrombin. The time taken for a clot to form is measured in seconds. The normal range for thrombin time is typically between 14 to 19 seconds, but this can vary depending on the laboratory and the specific reagents used.
Clinical Significance[edit | edit source]
A prolonged thrombin time can indicate several conditions:
- Hypofibrinogenemia or afibrinogenemia: Low levels of fibrinogen in the blood.
- Dysfibrinogenemia: Abnormal fibrinogen molecules that do not function properly.
- Heparin therapy: The presence of heparin, an anticoagulant, can prolong thrombin time.
- Direct thrombin inhibitors: Medications such as dabigatran can also prolong thrombin time.
Interpretation[edit | edit source]
The thrombin time is often used in conjunction with other coagulation tests such as the prothrombin time (PT) and the activated partial thromboplastin time (aPTT) to provide a comprehensive assessment of the coagulation system. A normal thrombin time with prolonged PT and aPTT may suggest a specific inhibitor or factor deficiency.
Limitations[edit | edit source]
The thrombin time is sensitive to the presence of heparin and other direct thrombin inhibitors, which can lead to falsely prolonged results. Therefore, it is important to consider the patient's medication history when interpreting the results.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
